Skip to main content
T

Taiyen Biotech Co., Ltd. — Investor Relations & Filings

Ticker · 1737 TW Manufacturing
Open in API
Filings indexed 1,609 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country TW Taiwan
Listing TW 1737

About Taiyen Biotech Co., Ltd.

https://www.tybio.com.tw/

Taiyen Biotech Co., Ltd. is a specialized enterprise focused on marine science and biotechnology. Building on its legacy as a national salt producer, the company has diversified into five core product categories: salt, bottled water, health supplements, skincare, and personal care. Its portfolio includes iodized and low-sodium salts, alkaline ion water processed through patented electrodialysis, and functional health foods utilizing microbial fermentation technologies. Taiyen maintains high manufacturing standards, operating a medical-grade collagen GMP facility and Halal-certified cosmetic production lines. The company integrates marine-derived resources with advanced R&D to provide health-oriented consumer goods and medical devices, emphasizing innovation and efficiency in the biotechnology sector.

Recent filings

Filing Released Lang Actions
公司基本資料
Regulatory Filings
2026-05-04 Chinese
公告115年第一季財務報告董事會預計召開日期為 115年5月8日
Regulatory Filings
2026-04-30 Chinese
115年3月背書保證與資金貸與
Regulatory Filings Classification · 1% confidence The document is a routine disclosure to Taiwan’s “公開資訊觀測站” showing monthly loan and guarantee balances (all zero). It is a mandatory regulatory compliance filing rather than an annual/quarterly report or announcement of capital changes, dividends, etc. Therefore it falls under the general Regulatory Filings category (RNS).
2026-04-10 Chinese
115年3月營業收入
Regulatory Filings Classification · 0% confidence The document text is an error message indicating that the page cannot be accessed and contains no substantive filing content. It does not match any specific category criteria, so by default it falls into the general Regulatory Filings (RNS) fallback category.
2026-04-10 Chinese
115年03月內部人持股異動(事後)
Director's Dealing Classification · 1% confidence The document is a detailed insider shareholding disclosure (“內部人持股變動”) listing directors, executives, their initial and end-of-month share counts, and changes during the period. This falls under insider trading/shareholding transaction reporting rather than an earnings release or general regulatory notice. The appropriate category is Director’s Dealing (DIRS).
2026-04-02 Chinese
115年03月董事會成員及持股
Director's Dealing Classification · 1% confidence The document is a statutory insider shareholding disclosure listing each director, supervisor, and senior manager’s shareholdings (at appointment and current), pledged shares, and related party holdings. This aligns with “Director’s Dealing” category (reports of insider share transactions/holdings).
2026-04-02 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.